Navigation Links
IGF-I

ProductsIGF-I
Company Nichols Institute Diagnostics
Item IGF-I
Features 
Description Insulin-like growth factor I or somatomedin-C, is a peptide highly dependent on growth hormone and has potent growth promoting activity. IGF-I is transported in serum by several IGF-binding proteins. In the diagnosis of growth disorders, measurements of IGF-I are a useful adjunct to assessment of growth hormone secretion. A normal plasma or serum IGF-I concentration is strong evidence against GH deficiency, with exceptions being some GH deficient children with craniopharyngiomas and adults who have a prolactin secreting tumor accompanied with GH deficiency and prolactin excess.
Info Nichols Institute Diagnostics
Customer Service: (949) 940-7200
Web site: http://www.nicholsdiag.com/index.htm

Related medicine products :

1. Insulin-like Growth Factor-I (IGF-I) ELISA
2. IMMULITE/IMMULITE 1000 IGF-I
3. IMMULITE 2500 IGF-I
4. IMMULITE 2000 IGF-I
5. Free IGF-I ELISA Test
6. IGF-I ELISA Test (Non-Extraction)
7. IGF-I IRMA Test (Non-Extraction)
8. IGF-I ELISA Test (With Extraction)
9. IGF-I IRMA Test (With Extraction)
10. Free IGF-I IRMA Test
11. IGF-II, Non-Extraction ELISA Test
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products:
(Date:6/20/2013)... The ISA (International Seabuckthorn Association) founded ... announced their 6th annual international conference to take place ... , Bruce McMullin , Founder and CEO of ... for introducing the benefits of sea buckthorn to the ... Sibu grows and harvests sea buckthorn berries in the ...
(Date:6/20/2013)... Indianapolis, IN (PRWEB) June 20, 2013 ... Many employers are concerned that this cost percentage will ... burden of caring for both aging parents and adult ... claims management can either provide workers a road block, ... , United Benefit Advisors (UBA), in ...
(Date:6/20/2013)... York, New York (PRWEB) June 20, 2013 ... protein folding and misfolding, Navneet Tyagi has ... Alzheimer’s disease. Throughout the myriad of scientific research that ... his commitment of identifying early onset of these severe ... through early diagnosis, more medical researchers will be able ...
(Date:6/20/2013)... Denton, TX (PRWEB) June 20, 2013 ... has maintained a wide range of outpatient and inpatient ... psychiatric issues, including those who are children. As a ... UBH explains that it is critical to diagnose mental ... action. However, according to a recent article ...
(Date:6/20/2013)... June 20, 2013 Rampant staph infections ... to fight this scourge is being successfully deployed by ... direct contact and by touching items that are contaminated ... As noted by the San Francisco Chronicle , ... become infected during hospital stays, and at least 90,000 ...
Breaking Medicine News(10 mins):Health News:Sibu, LLC CEO, Bruce McMullin to be Amongst Distinguished Attendees at ISA Conference 2Health News:United Benefit Advisors and Symetra Host Absence Management Webinar 2Health News:United Benefit Advisors and Symetra Host Absence Management Webinar 3Health News:Navneet Tyagi Supports Continued Efforts for Alzheimer Detection Procedures 2Health News:Navneet Tyagi Supports Continued Efforts for Alzheimer Detection Procedures 3Health News:New Statistics Indicate Increase in Mental Health Issues Among Children, UBH Denton Responds 2Health News:New Statistics Indicate Increase in Mental Health Issues Among Children, UBH Denton Responds 3Health News:Lab Testing Reveals EnviroTextile's Hemp Fabric Stops the Spread of Staph Bacteria 2Health News:Lab Testing Reveals EnviroTextile's Hemp Fabric Stops the Spread of Staph Bacteria 3
... gene respond well to targeted therapy , , SUNDAY, June ... the normal version of a particular gene are more ... adding the targeted therapy Erbitux to chemotherapy. , Some ... "wild-type" form of the gene, according to the new ...
... cells, hasten death, study says , , SUNDAY, June 1 ... in cancer patients may actually speed progression of the ... found a way to determine who those individuals are. ... whether a patient is susceptible to having their tumor ...
... study suggests , , SUNDAY, June 1 (HealthDay News) -- ... value in helping to prevent lung cancer. , Researchers ... on the U.S. market, may reduce levels of a ... presented its findings Sunday at the American Society of ...
... combination of two different biotherapies may be beneficial for ... Pittsburgh Cancer Institute (UPCI) study presented at the 44th ... (ASCO) in Chicago. , Researchers in the melanoma and ... treatments that stimulate the immune system to fight cancer ...
... common types, study says , , SUNDAY, June 1 (HealthDay News) ... or adolescents are much more likely than other people to ... disease (HD), a cancer of the lymph nodes, has a ... be at future risk of developing second cancers other than ...
... in determining how much fathers get involved in taking care ... of 97 couples found that fathers were more involved in ... encouragement from their wife or partner. , In fact, this ... mothers views about how involved dads should be, the overall ...
Cached Medicine News:Health News:Erbitux Works Well for Two-Thirds of Colon Cancer Patients 2Health News:Erbitux Works Well for Two-Thirds of Colon Cancer Patients 3Health News:Anemia Drugs May Speed Tumor Growth in Some Cancer Patients 2Health News:Anemia Drugs May Speed Tumor Growth in Some Cancer Patients 3Health News:Celebrex May Reduce Levels of Lung Cancer Biomarker 2Health News:Celebrex May Reduce Levels of Lung Cancer Biomarker 3Health News:Young Hodgkin Survivors Face Later Risk of Second Cancers 2Health News:Mom's behavior key to dad's involvement in child care 2Health News:Mom's behavior key to dad's involvement in child care 3
(Date:6/20/2013)... WESTMINSTER, Colo. , June 20, 2013 ... Surefire Medical today announced a sales and marketing partnership ... catheters for the interventional radiology and oncology markets. ... range of products in the company,s rapidly growing ... . Sirtex reported a 30 per cent growth ...
(Date:6/20/2013)... , June 20, 2013 Today ... mark the launch of a new programme to control the ... Jacobina in the State of Bahia. In previous ... is possible to rapidly reduce the number of dengue mosquitoes ... the level of these mosquitoes were reduced by 96% within ...
(Date:6/19/2013)... 2013 Pharmacyclics, Inc. (the "Company") (Nasdaq: ... England Journal of Medicine ( NEJM ) published ... oral Bruton,s tyrosine kinase (BTK) inhibitor ibrutinib in patients ... suggested ibrutinib may be effective and generally well-tolerated in ... a separate study examining the safety and efficacy of ...
Breaking Medicine Technology:Sirtex To Distribute Surefire Medical's Innovative Infusion System in Australia and Asia Pacific Markets 2Moscamed Launches Urban Scale Project Using Oxitec GM Mosquitoes in Battle Against Dengue 2Moscamed Launches Urban Scale Project Using Oxitec GM Mosquitoes in Battle Against Dengue 3Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 2Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 3Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 4Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 5Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 6